Forsøgspersonerne fik Rapamune (med målkoncentrationer af sirolimus på 5 til 15 ng/ ml) i kombination med en calcineurinhæmmer og kortikosteroider, eller de fik calcineurinhæmmerbaseret immunosuppression uden Rapamune.
Subjects were to receive Rapamune (sirolimus target concentrations of 5 to 15 ng/ mL) in combination with a calcineurin inhibitor and corticosteroids or to receive calcineurin-inhibitor-based immunosuppression without Rapamune.